Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Trigger Finger Disorder 1Pain, Postoperative 1Mucositis 1Median Neuropathy 1Head and Neck Neoplasms 1Ganglion Cysts 1De Quervain Disease 1Breast Neoplasms 1Abnormalities, Radiation-Induced 1

Interventions

Radiotherapy 7Cisplatin 6Fibroblast Growth Factor 7 3Water 2Radiation 2Low-Level Light Therapy 2Injections 2peppermint oil 1pegfilgrastim 1oxycodone-acetaminophen 1kang-lai-te 1cyclohexaneacetic acid 1brilacidin 1anise oil 1acetaminophen, hydrocodone drug combination 1Xylitol 1Tramadol 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sorbic Acid 1Selenomethionine 1Saline Solution 1RRx-001 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Pain Management 1Neck Dissection 1Methods 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mucositis × oxycodone-acetaminophen × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡